ReviewTherapeutics and clinical risk management2020

Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach.

Sherif M Hamdy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.